Your Pet Is Our Top Priority

Elanco stands behind the safety profile for Seresto and therefore no market action, such as a recall, is warranted, nor has it been suggested from any regulatory agency.

It is critically important to understand that a report is not an indication of cause. Since its initial approval in 2012, more than 25 million Seresto collars have protected dogs and cats in the U.S. from fleas and ticks that can transmit disease and can impact their quality of life.

There is no established link between death and exposure to the active ingredients contained in Seresto. The incident report rate for all adverse events related to Seresto in the U.S. has been below 0.3%. Furthermore, the significant majority of these incidents relate to non-serious effects, such as dermatologic application site issues.

As a globally distributed product, Seresto’s safety data was rigorously reviewed over the course of its development prior to registration by more than 80 regulatory authorities around the world, including the U.S. EPA. Importantly, as regulated by the EPA, Seresto remains available on the market.